Stop Drug Waste From Shrinking Your Bottom Line

Why This Topic Matters

Wasted injectable drugs can affect reimbursement and practice revenue, so understanding how payers handle discarded amounts helps support accurate claims and compliant documentation.

Article Sections

1. Account for Waste

   This section covers billing considerations for botulinum toxin supplies, documentation expectations, and distinctions between related drug products. It also introduces payer review considerations and a common clinical use area.

2. Schedule for Maximum Efficiency

   This section discusses scheduling and workflow approaches intended to reduce waste and describes claim reporting concepts for multiple patients treated from the same supply.

3. Third-Party Payers May Differ

   This section notes that payer policies may vary on how discarded drug amounts are reported and emphasizes checking individual payer guidance.